Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Dynavax Technologies Corporation (DVAX)

8.66   -0.52 (-5.66%) 07-10 16:00
Open: 9.11 Pre. Close: 9.18
High: 9.18 Low: 8.52
Volume: 4,027,874 Market Cap: 942M
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Its immuno-oncology portfolio includes development stage products, such as SD-101 and DV281. Dynavax Technologies Corporation has a research collaboration with Clover Biopharmaceuticals; the University of Queensland and the Coalition for Epidemic Preparedness; and Sinovac Biotech Ltd. for the development of a vaccine candidate to prevent coronavirus (COVID-19). Dynavax Technologies Corporation has partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against COVID-19 infection; and a collaboration with Valneva SE to initiate a vaccine program for the coronavirus, COVID-19.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.184 - 9.246 9.246 - 9.297
Low: 8.408 - 8.465 8.465 - 8.512
Close: 8.575 - 8.669 8.669 - 8.747

Technical analysis

as of: 2020-07-10 4:27:07 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 11.40     One year: 13.31
Support: Support1: 7.05    Support2: 5.38
Resistance: Resistance1: 9.76    Resistance2: 11.40
Pivot: 8.29
Moving Average: MA(5): 8.91     MA(20): 7.74
MA(100): 4.91     MA(250): 4.87
MACD: MACD(12,26): 0.85     Signal(9): 0.82
Stochastic oscillator: %K(14,3): 81.31     %D(3): 81.20
RSI: RSI(14): 60.00
52-week: High: 9.76  Low: 1.80  Change(%): 114.4
Average Vol(K): 3-Month: 686756  10-Days: 695603

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
DVAX has closed below upper band by 39.2%. Bollinger Bands are 50.9% wider than normal. The large width of the bands suggest high volatility as compared to DVAX's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Fri, 10 Jul 2020
Dynavax Technologies Corporation (DVAX) Plunges 5.66% on July 10 - Equities.com

Wed, 08 Jul 2020
If You Had Bought Dynavax Technologies (NASDAQ:DVAX) Shares A Year Ago You'd Have Earned133% Returns - Yahoo Finance

Wed, 08 Jul 2020
Dynavax and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Vaccine Candidate - Yahoo Finance

Tue, 07 Jul 2020
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't? - Yahoo Finance

Sun, 05 Jul 2020
Is Dynavax Technologies Stock a Buy? - The Motley Fool

Thu, 02 Jul 2020
Dynavax Technologies Corporation (DVAX) Soars 4.33% on July 02 - Equities.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 109
Shares Float (M) 84
% Held by Insiders 1.15
% Held by Institutions 73.91
Shares Short (K) 12,580
Shares Short P. Month (K) 11,930

Stock Financials

EPS -1.780
EPS Est This Year -1.630
EPS Est Next Year -1.540
Book Value (p.s.) 0.140
Profit Margin
Operating Margin -243.78
Return on Assets (ttm) -22.1
Return on Equity (ttm) -456.6
Qtrly Rev. Growth 89.1
Gross Profit (p.s.) -0.343
Sales Per Share 0.371
EBITDA (p.s.) -0.771
Qtrly Earnings Growth
Operating Cash Flow (M) -108
Levered Free Cash Flow (M) -102

Stock Valuations

PE Ratio -4.87
PEG Ratio
Price to Book value 61.86
Price to Sales 23.34
Price to Cash Flow -8.71

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.